Both in Pharmaceuticals
ArriVent BioPharma vs Lexicon Pharmaceuticals
Over the past year AVBP returned −24.1% and LXRX returned +7.7%; their daily moves had a correlation of 0.12.
AVBP −24.1% LXRX +7.7%Growth of $1, one year, split-adjusted
| Metric | AVBP | LXRX |
|---|---|---|
| Price | $13.35 | $1.47 |
| Market cap | $658.3M | $651.9M |
| Today | 0.00% | +1.74% |
| 1 month | −53.1% | −15.8% |
| 6 months | −55.2% | −11.2% |
| Year to date | −33.6% | +27.4% |
| 1 year | −28.7% | +6.2% |
| Revenue growth (YoY) | — | −97.6% |
| Gross margin | — | 94.4% |
| Net margin | — | −4591.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 15.8× |
| Net cash | $373.1M | $139.2M |
| Dividend yield | — | — |
| Volatility (60d) | 154.4% | 52.0% |
| Short % of float | 20.3% | 11.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).